Artwork

Content provided by Locust Walk. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Locust Walk or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 2: Bradley Campbell, Amicus Therapeutics

33:15
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on October 25, 2020 03:10 (3+ y ago). Last successful fetch was on August 30, 2019 02:27 (4+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 212361253 series 2394469
Content provided by Locust Walk. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Locust Walk or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode of Biotalk podcast, Josh Hamermesh, Vice President of Locust Walk interviews Bradley Campbell, President& COO of Amicus Therapeutics. Amicus is very much at the forefront developing and commercializing important therapies to treat a range of devastating rare and orphan diseases. In fact, this has been an eventful and exciting week at Amicus as the company announced the launch of Galafold in the UK. Galafold is the first oral treatment as well as the first precision medicine product for patients with Fabry’s Disease patients.

  continue reading

5 episodes

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on October 25, 2020 03:10 (3+ y ago). Last successful fetch was on August 30, 2019 02:27 (4+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 212361253 series 2394469
Content provided by Locust Walk. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Locust Walk or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode of Biotalk podcast, Josh Hamermesh, Vice President of Locust Walk interviews Bradley Campbell, President& COO of Amicus Therapeutics. Amicus is very much at the forefront developing and commercializing important therapies to treat a range of devastating rare and orphan diseases. In fact, this has been an eventful and exciting week at Amicus as the company announced the launch of Galafold in the UK. Galafold is the first oral treatment as well as the first precision medicine product for patients with Fabry’s Disease patients.

  continue reading

5 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide